The evolving role of inflammation in obesity and the metabolic syndrome

被引：17

作者：

Lee Y.-H. ^{[1
]}

Pratley R.E. ^{[1
]}

机构：

[1] Diabet./Metabolism Transl. Med. Unit, Division of Endocrinology/Metabolism, Univ. of Vermont College of Medicine, Burlington, VT 05401, One South Prospect Street

来源：

Current Diabetes Reports | 2005年 / 5卷 / 1期

关键词：

Obesity; Insulin Resistance; Adipose Tissue; Metabolic Syndrome; Insulin Action;

D O I：

10.1007/s11892-005-0071-7

中图分类号：

学科分类号：

摘要：

Advances in adipose tissue biology over the past 10 years have led to an improved understanding of the mechanisms linking obesity with the metabolic syndrome and other complications. Obesity is characterized by a chronic, systemic low-grade state of inflammation. Biomarkers of inflammation, such as the leukocyte count, tumor necrosis factor-α (TNF-α), interleukin 6 (IL-6), and C-ractive protein, are increased in obesity, associated with insullin resistance, and predict the development of type 2 diabetes and cardiovascular disease. It is now clear that the adipocyte is an active participant in the generation of the inflammatory state in obesity. Adipocytes secrete a variety of cytokines, including IL-6 and TNF-α, that promote inflammation. Moreover, recent studies suggest that obesity is associated with an increase in adipose tissue macrophages, which also participate in the inflammatory process through the elaboration of cytokines. An improved understanding of the role of adipose tissue in the activation of inflammatory pathways may suggest novel treatmant and prevention strategies aimed at reducing obesity-associated morbidities and mortality. Copyright © 2005 by Current Science Inc.

引用

页码：70 / 75

页数：5

共 49 条

[31]

Vozarova B., Weyer C., Lindsay R.S., Et al., High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes, Diabetes, 51, pp. 455-461, (2002)

[32]

Kannel W.B., Anderson K., Wilson P.W., White blood cell count and cardiovascular disease. Insights from the Framingham Study, JAMA, 267, pp. 1253-1256, (1992)

[33]

Ridker P.M., High-sensitivity C-reactive protein: Potential adjunct for global risk assessment in the primary prevention of cardiovascular disease, Circulation, 103, pp. 1813-1818, (2001)

[34]

Maffei M., Fei H., Lee G.H., Et al., Increased expression in adipocytes of ob RNA in mice with lesions of the hypothalamus and with mutations at the db locus, Proc. Natl. Acad. Sci. U. S. A., 92, pp. 6957-6960, (1995)

[35]

Maffei M., Halaas J., Ravussin E., Et al., Leptin levels in human and rodent: Measurement of plasma leptin and obRNA in obese and weight-reduced subjects, Nat. Med., 1, pp. 1155-1161, (1995)

[36]

Maeda K., Okubo K., Shimomura I., Et al., cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1), Biochem. Biophys. Res. Commun., 221, pp. 286-289, (1996)

[37]

Weyer C., Funahashi T., Tanaka S., Et al., Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia, J. Clin. Endocrinol. Metab., 86, pp. 1930-1935, (2001)

[38]

Klaus S., Keijer J., Gene expression profiling of adipose tissue: Individual, depot-dependent, and sex-dependent variabilities, Nutrition, 20, pp. 115-120, (2004)

[39]

Soukas A., Socci N.D., Saatkamp B.D., Et al., Distinct transcriptional profiles of adipogenesis in vivo and in vitro, J. Biol. Chem., 276, pp. 34167-34174, (2001)

[40]

Xu H., Barnes G.T., Yang Q., Et al., Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance, J. Clin. Invest., 112, pp. 1821-1830, (2003)

← 1 2 3 4 5 →